Bionovate Technologies Corp. (BIIO) financial statements (2020 and earlier)

Company profile

Business Address ROTHSCHILD BLVD 22
TEL AVIV-YAFO, 6688218
State of Incorp. NV
Fiscal Year End June 30
SIC 364 - Electric Lighting And Wiring Equipment (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments    111
Cash and cash equivalents    111
Total current assets:    111
Noncurrent Assets
Intangible assets, net (including goodwill)  20   
Intangible assets, net (excluding goodwill)  20    
Total noncurrent assets:  20    
TOTAL ASSETS:  20 111
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1361084139212218
Accounts payable    212218
Accrued liabilities91 24    
Other undisclosed accounts payable and accrued liabilities451081739   
Debt184418343   
Due to related parties41411861471309566
Other undisclosed current liabilities 143     
Total current liabilities:36133231022915211784
Noncurrent Liabilities
Total liabilities:36133231022915211784
Stockholders' equity
Stockholders' equity attributable to parent, including:(361)(332)(310)(229)(151)(116)(83)
Common stock2220222
Additional paid in capital2,2432,2422,056383112112112
Accumulated other comprehensive income (loss)   141612(3)
Accumulated deficit(2,606)(2,576)(2,367)(627)(280)  
Other undisclosed stockholders' equity attributable to parent     (242)(194)
Total stockholders' equity:(361)(332)(310)(229)(151)(116)(83)
TOTAL LIABILITIES AND EQUITY:    111

Income statement (P&L) ($ in thousands)

9/30/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Revenues   5648
Cost of revenue
(Cost of Goods and Services Sold)
   (4)(5)(4)(10)
Gross profit:   111(2)
Operating expenses(55)(57)(119)(89)(39)(49)(89)
Operating loss:(55)(57)(119)(88)(38)(48)(91)
Nonoperating expense(96)(152)(1,622)(253)   
Debt instrument, convertible, beneficial conversion feature101101     
Interest and debt expense(47)(51)(16)(61)   
Loss from continuing operations before income taxes:(198)(260)(1,757)(402)(38)(48)(91)
Other undisclosed income from continuing operations47511661   
Loss from continuing operations:(151)(209)(1,741)(341)(38)(48)(91)
Income from discontinued operations   17   
Net loss:(151)(209)(1,741)(324)(38)(48)(91)
Net income attributable to noncontrolling interest   1   
Other undisclosed net loss attributable to parent   (1)   
Net loss attributable to parent:(151)(209)(1,741)(324)(38)(48)(91)
Other undisclosed net income available to common stockholders, basic   1   
Net loss available to common stockholders, diluted:(151)(209)(1,741)(323)(38)(48)(91)

Comprehensive Income ($ in thousands)

9/30/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Net loss:(151)(209)(1,741)(324)(38)(48)(91)
Other comprehensive income (loss)(46)(45)(65)(30)415(0)
Comprehensive loss:(196)(254)(1,806)(354)(34)(33)(92)
Comprehensive income, net of tax, attributable to noncontrolling interest   1   
Other undisclosed comprehensive income, net of tax, attributable to parent46455128   
Comprehensive loss, net of tax, attributable to parent:(151)(209)(1,755)(325)(34)(33)(92)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: